Alexion Pharmaceuticals, Inc. group: subsidiaries and structure
Corporation · Wilmington, United States · LEI M1YXUUZR0EIMU8T0EM75
4subsidiaries
3countries
0held directly
4lapsed LEIs
4links on accounts older than 24 months
0ISINs of subsidiaries
Summary
Alexion Pharmaceuticals, Inc. is the ultimate parent of 4 subsidiaries with LEIs in 3 countries, as reported to GLEIF. 0 are held directly; the others sit below intermediate companies. The largest numbers are in Ireland (2), in Switzerland (1) and in India (1). 4 of the subsidiaries have a lapsed LEI, and 4 links rest on accounts older than 24 months. GLEIF's ISIN mapping lists 3 ISINs for the parent and 0 ISINs for its subsidiaries.
Written from GLEIF data using fixed, reviewed sentence templates.
Subsidiaries by country
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 13 Jan 2019 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
4 subsidiaries have data-quality notes; they are listed on each company page.
Group structure
Indentation shows the direct parent reported to GLEIF.
Subsidiaries
| Company | Country | City | LEI | Accounts year | Notes |
|---|---|---|---|---|---|
| ALEXION PHARMA GMBH | Switzerland | ZURICH | DWCRFHBH0B4E23GPAD03 | 2018 | lapsed > 24 months |
| ALEXION PHARMA HOLDING UNLIMITED COMPANY | Ireland | DUBLIN | 549300L03GTO5EKVPK43 | 2016 | lapsed > 24 months |
| ALEXION PHARMA INTERNATIONAL OPERATIONS UNLIMITED COMPANY | Ireland | DUBLIN | 549300JMB1ILG4YU8N48 | 2020 | lapsed > 24 months |
| Alexion Business Services Private Limited | India | Mumbai | 2549009SUYLMUZ0CIY84 | 2019 | lapsed > 24 months |